A Canadian multicenter study of 115 children shows that new CHEST guideline criteria and REM-sleep-specific measures detect ...
Detecting impaired motor function as early as possible after birth with the help of a standard camera linked to intelligent ...
Detecting impaired motor function in infants using AI-driven motion capture is producing promising results. A French research ...
For people with muscular dystrophy, who may experience problems with muscle strength, endurance, balance, joint stiffness, ...
On Tuesday, Argenx SE announced that it will present new clinical, long-term and real-world data for VYVGART (efgartigimod) across Myasthenia gravis and Chronic inflammatory demye ...
Deciding when a child with a neuromuscular disease should begin non-invasive ventilation is one of the most consequential ...
Sufferers of complex, chronic diseases like POTS and long COVID often spend years searching for relief. The longtime tech ...
Italfarmaco S.p.A., a global pharmaceutical company with established expertise in histone deacetylase (HDAC) biology and therapeutic development, and VeriSIM Life, an AI-enabled drug discovery and ...
Muscular Dystrophy Canada has launched a new national registry aimed at collecting Canadian-specific information from people ...
Muscular Dystrophy Canada is proud to announce the launch of the Neuromuscular Disease Real-World eXperience Registry (NMD-RWx). This ...
In exploratory analyses at Month 12, among individuals with LGMD2I/R9 (FKRP-related) with elevated HS troponin I at baseline, 100% treated with ...
New data show deepening improvement in ocular MG and sustained one-year efficacy in anti-AChR antibody-negative MG – broadening VYVGART's potential to treat all MG patientsReal-world evidence from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results